𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan

✍ Scribed by Ooe, Yokiko; Nagai, Tomoko

Book ID
121573769
Publisher
Springer
Year
2014
Tongue
English
Weight
233 KB
Volume
3
Category
Article
ISSN
2193-1801

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Successful liver transplantation for Bud
Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab
✍ Andrew L. Singer; Jamye E. Locke; Zoe A. Stewart; Bonnie E. Lonze; James P. Hami πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 173 KB

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hemolytic anemia caused by somatic mutations in the phosphatidylinositol glycan-complementation class A gene and the resulting absence of a key complement regulatory protein, CD59. Affected red blood cells in patients with PNH undergo int

Long-term effect of the complement inhib
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
✍ Peter Hillmen; Modupe Elebute; Richard Kelly; Alvaro Urbano-Ispizua; Anita Hill; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 2 views

## Abstract Paroxysmal nocturnal hemoglobinuria (PNH) is a debilitating and life‐threatening disease in which lysis of PNH red blood cells frequently manifests with chronic hemolysis, anemia, and thrombosis. Renal damage in PNH is associated with chronic hemosiderosis and/or microvascular thrombosi